Newly discovered small-molecule TNF inhibitors serve as antagonists of pro-inflammatory TNF signalling by uniquely harnessing the conformational plasticity of trimeric TNF. The development of this approach could mark a resurgence of non-biologic modulators of clinically relevant protein–protein interactions in rheumatology.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking
Chinese Medicine Open Access 30 July 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kalliolias, G. D. & Ivashkiv, L. B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol. 12, 49–62 (2016).
Steeland, S., Libert, C. & Vandenbroucke, R. E. A new venue of TNF targeting. Int. J. Mol. Sci. 19, 1442 (2018).
Jairath, V. & Feagan, B. G. Global burden of inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 5, 2–3 (2020).
O’Connell, J. et al. Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nat. Commun. 10, 5795 (2019).
Scott, D. E., Bayly, A. R., Abell, C. & Skidmore, J. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat. Rev. Drug Discov. 15, 533–550 (2016).
He, M. M. et al. Small-molecule inhibition of TNF-alpha. Science 310, 1022–1025 (2005).
Davis, J. M. & Colangelo, J. Small-molecule inhibitors of the interaction between TNF and TNFR. Future Med. Chem. 5, 69–79 (2013).
Mak, K. K. & Pichika, M. R. Artificial intelligence in drug development: present status and future prospects. Drug Discov. Today 24, 773–780 (2019).
Nair, N. & Wilson, A. G. Can machine learning predict responses to TNF inhibitors? Nat. Rev. Rheumatol. 15, 702–704 (2019).
Kingsmore, K. M., Grammer, A. C. & Lipsky, P. E. Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nat. Rev. Rheumatol. 16, 32–52 (2020).
Acknowledgements
S.N.S. is supported by grants from Research Foundation Flanders-Belgium (FWO), Ghent University and VIB, Belgium. D.E. acknowledges support from FWO and VIB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Savvides, S.N., Elewaut, D. Small-molecule inhibitors get pro-inflammatory TNF into shape. Nat Rev Rheumatol 16, 189–190 (2020). https://doi.org/10.1038/s41584-020-0388-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0388-2